Eglesia, Severina .
HRN: 21-95-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
CEFTAZIDIME 1GM (VIAL)
10/13/2022
10/19/2022
IVT
1g
Q8
PTB, CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes